Intragastric botulinum toxin injection: a promising alternative for obesity treatment?

Introduction Over the past 50 years, the rise in obesity has prompted a search for new treatments. Intragastric injections of botulinum toxin A (BT-A), a safer alternative to surgery, show promise in reducing weight and caloric intake by inducing early satiety. This study examines their efficacy for...

Full description

Saved in:
Bibliographic Details
Main Authors: Hakan Balbaloglu, Ilhan Tasdoven, Ipek Yorgancioglu
Format: Article
Language:English
Published: Termedia Publishing House 2024-10-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/Intragastric-botulinum-toxin-injection-a-promising-alternative-for-obesity-treatment,178334,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584881734942720
author Hakan Balbaloglu
Ilhan Tasdoven
Ipek Yorgancioglu
author_facet Hakan Balbaloglu
Ilhan Tasdoven
Ipek Yorgancioglu
author_sort Hakan Balbaloglu
collection DOAJ
description Introduction Over the past 50 years, the rise in obesity has prompted a search for new treatments. Intragastric injections of botulinum toxin A (BT-A), a safer alternative to surgery, show promise in reducing weight and caloric intake by inducing early satiety. This study examines their efficacy for weight loss. Material and methods From 2021 to 2023, we conducted a retrospective analysis of patients who underwent intragastric BT-A injections in a general surgery endoscopy unit. The inclusion criteria were being aged 18–65 and having a body mass index (BMI) over 25 kg/m 2 . Patients with specific medical conditions or incomplete records were excluded. We monitored patient weight and BMI values before the procedure and at monthly intervals, with further assessments conducted in the sixth month, including appetite and patient satisfaction. Results Our study on 67 patients, predominantly female (82.1%), aged 35.5 ±9.0 years with a mean BMI of 33.5 ±3.3 kg/m², examined BT-A injections’ effectiveness. 58.2% received injections in both gastric antrum and fundus regions, showing greater weight loss (mean: 10.7 ±7.0 kg) than those treated in the antrum alone. Side effects occurred in 16.4%, with various symptoms. High dietary compliance (80.6%) correlated with weight loss, especially among those reporting intense satiety. Patient satisfaction positively correlated with weight loss, highlighting treatment efficacy and patient response to dual-region injections. Conclusions Our study suggested that intragastric BT-A injections in the antrum and fundus are effective and safe for satiety and weight loss, with few side effects. Individual responses vary, and diet adherence is crucial. More studies are needed to assess the treatment’s efficacy in obesity.
format Article
id doaj-art-addca2a5955f4f068b1bfd9249ca6075
institution Kabale University
issn 1734-1922
1896-9151
language English
publishDate 2024-10-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj-art-addca2a5955f4f068b1bfd9249ca60752025-01-27T10:44:30ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512024-10-012051400140610.5114/aoms/178334178334Intragastric botulinum toxin injection: a promising alternative for obesity treatment?Hakan Balbaloglu0Ilhan Tasdoven1Ipek Yorgancioglu2Department of General Surgery, Bülent Ecevit University School of Medicine, Zonguldak, TurkeyDepartment of General Surgery, Bülent Ecevit University School of Medicine, Zonguldak, TurkeyDepartment of General Surgery, Bülent Ecevit University School of Medicine, Zonguldak, TurkeyIntroduction Over the past 50 years, the rise in obesity has prompted a search for new treatments. Intragastric injections of botulinum toxin A (BT-A), a safer alternative to surgery, show promise in reducing weight and caloric intake by inducing early satiety. This study examines their efficacy for weight loss. Material and methods From 2021 to 2023, we conducted a retrospective analysis of patients who underwent intragastric BT-A injections in a general surgery endoscopy unit. The inclusion criteria were being aged 18–65 and having a body mass index (BMI) over 25 kg/m 2 . Patients with specific medical conditions or incomplete records were excluded. We monitored patient weight and BMI values before the procedure and at monthly intervals, with further assessments conducted in the sixth month, including appetite and patient satisfaction. Results Our study on 67 patients, predominantly female (82.1%), aged 35.5 ±9.0 years with a mean BMI of 33.5 ±3.3 kg/m², examined BT-A injections’ effectiveness. 58.2% received injections in both gastric antrum and fundus regions, showing greater weight loss (mean: 10.7 ±7.0 kg) than those treated in the antrum alone. Side effects occurred in 16.4%, with various symptoms. High dietary compliance (80.6%) correlated with weight loss, especially among those reporting intense satiety. Patient satisfaction positively correlated with weight loss, highlighting treatment efficacy and patient response to dual-region injections. Conclusions Our study suggested that intragastric BT-A injections in the antrum and fundus are effective and safe for satiety and weight loss, with few side effects. Individual responses vary, and diet adherence is crucial. More studies are needed to assess the treatment’s efficacy in obesity.https://www.archivesofmedicalscience.com/Intragastric-botulinum-toxin-injection-a-promising-alternative-for-obesity-treatment,178334,0,2.htmlbotulinum toxin agastric motilityobesityweight loss
spellingShingle Hakan Balbaloglu
Ilhan Tasdoven
Ipek Yorgancioglu
Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
Archives of Medical Science
botulinum toxin a
gastric motility
obesity
weight loss
title Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
title_full Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
title_fullStr Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
title_full_unstemmed Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
title_short Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
title_sort intragastric botulinum toxin injection a promising alternative for obesity treatment
topic botulinum toxin a
gastric motility
obesity
weight loss
url https://www.archivesofmedicalscience.com/Intragastric-botulinum-toxin-injection-a-promising-alternative-for-obesity-treatment,178334,0,2.html
work_keys_str_mv AT hakanbalbaloglu intragastricbotulinumtoxininjectionapromisingalternativeforobesitytreatment
AT ilhantasdoven intragastricbotulinumtoxininjectionapromisingalternativeforobesitytreatment
AT ipekyorgancioglu intragastricbotulinumtoxininjectionapromisingalternativeforobesitytreatment